01
Construct
Build and Edit
Generate wild-type and variant L1CAM expression constructs, or introduce specific variants by gene editing into a defined cell line or stem-cell background.
Gene Function, Variants, and Disease Evidence
L1CAM and Associated Diseases
L1CAM encodes the L1 cell adhesion molecule, a type I membrane glycoprotein of the immunoglobulin superfamily essential for nervous system development. Pathogenic variants cause a spectrum of X-linked disorders collectively termed L1 syndrome. Creative Biolabs supports gene-function validation, disease modeling, and vector design for L1CAM-associated disease research.
Pathogenic variants in L1CAM can disrupt nervous system development, leading to congenital hydrocephalus, spastic paraplegia, intellectual disability, delayed speech, and abnormalities of the corpus callosum. These variants cause L1 syndrome, an X-linked disorder within the broader category of hereditary diseases, encompassing hydrocephalus with aqueductal stenosis (HSAS), MASA syndrome, and X-linked complicated corpus callosum agenesis. Disease severity varies considerably, ranging from severe congenital neurological abnormalities to milder motor and cognitive impairments, highlighting the importance of investigating central nervous system diseases and their underlying genetic mechanisms.
Gene functionNeuronal migration, axon guidance, adhesion, and synaptic plasticity in the central nervous system.
Disease associationL1 syndrome: HSAS, MASA syndrome, and partial agenesis of the corpus callosum (X-linked).
Evidence levelPathogenic variants are established; distinguish confirmed associations from inferred mechanisms.
Entity Identity and Expression
What is L1CAM, and where is it expressed?
The table below summarizes the standard gene identity and its normal expression. Distinguishing established functions from inferred ones is essential when interpreting variant effects and designing validation experiments.
01Gene symbol and nameL1CAM — L1 cell adhesion molecule. The protein is a type I membrane glycoprotein of the immunoglobulin superfamily with six immunoglobulin-like domains and five fibronectin type III domains.
02Protein and pathwayCell adhesion molecule (CAM); mediates interactions with other CAMs, extracellular matrix molecules, and signaling receptors to regulate neurite growth, adhesion, fasciculation, migration, myelination, and axon guidance.
03Species and chromosomal locationHomo sapiens; Xq28, an X-linked locus. The X-linked inheritance pattern is central to the male-predominant presentation of L1 syndrome.
04Authoritative database IDsHGNC: 6470; Ensembl: ENSG00000198910; UniProt: P32004; OMIM: 308840. These identifiers anchor variant and literature lookups to a consistent reference.
05Normal tissue and cell expressionPredominantly in the nervous system, including neurons, where it supports migration, axon growth, and synaptic plasticity. L1CAM is also reported in certain vascular and tumor-associated cell populations.
06Last verifiedLast verified November 2026 against HGNC, Ensembl, UniProt, and OMIM. Clinical-stage information, indications, and performance figures change over time and are not provided here.
Variant–Mechanism–Disease Evidence
Which diseases are associated with L1CAM variants?
Pathogenic L1CAM variants cause a spectrum of X-linked disorders known as L1 syndrome. Each module below summarizes the reported association, its supporting evidence, and its limitations. Associations are not presented as causal certainty, and this page does not provide diagnostic or treatment advice.
01X-linked Hydrocephalus with Aqueductal Stenosis (HSAS)
Hydrocephalus+
Mechanism and Reported Findings
- Loss-of-function L1CAM variants disrupt L1-mediated cell adhesion and signaling, impairing neuronal migration and the normal formation of the ventricular system and corpus callosum.
- HSAS is characterized by hydrocephalus secondary to stenosis of the aqueduct of Sylvius, often with adducted thumbs and intellectual disability in affected males.
- The association is well established in the literature and anchored to the OMIM entry for L1 syndrome.
Evidence and Interpretation
- Evidence: multiple case series and functional studies; X-linked recessive inheritance.
- Interpretation: a strong, established gene-disease relationship.
- Limit: phenotypic severity varies with the specific variant and genetic background.
02MASA Syndrome
MASA+
Mechanism and Reported Findings
- MASA syndrome (mental retardation, aphasia, shuffling gait, adducted thumbs) is a milder allelic disorder within the L1 syndrome spectrum.
- The shared molecular basis is impaired L1CAM function, with the phenotype reflecting the severity and location of the variant.
Evidence and Interpretation
- Evidence: allelic disorder confirmed by molecular diagnosis in affected families.
- Interpretation: established association; expressivity is variable.
- Limit: genotype-phenotype correlation remains incomplete.
03Partial Agenesis of the Corpus Callosum
CCA+
Mechanism and Reported Findings
- Some L1CAM variants present with isolated or partial agenesis of the corpus callosum without full hydrocephalus.
- This reflects L1CAM's role in axon guidance across the midline during early development.
Evidence and Interpretation
- Evidence: case reports and family studies.
- Interpretation: established association within the spectrum.
- Limit: CCA is genetically heterogeneous; L1CAM is one of several causes.
04L1CAM in Cancer Biology
Oncology+
Mechanism and Reported Findings
- L1CAM is abnormally expressed in the vasculature of several cancers and is enriched in metastatic and post-therapy relapse tumors relative to normal colonic epithelium.
- L1CAM has been studied as a target for radioimmunotherapy in neuroblastoma and as a prognostic marker.
Evidence and Interpretation
- Evidence: tumor expression studies and preclinical targeting work.
- Interpretation: a research association, not a clinical claim.
- Limit: oncogenic role is context-dependent and requires independent validation.
Testable Hypotheses and Models
How can an L1CAM variant effect be validated?
Candidate approaches range from cell-based assays to iPSC-derived neurons, organoids, and animal models. Each model answers a different question and carries its own readouts and limitations.
Cell linesAdhesion and migration
Scientific contextExpressing wild-type or variant L1CAM in neuronal cell lines enables focused measurement of adhesion, neurite outgrowth, and fasciculation in a defined system.
Interpretation boundaryCell-line results isolate molecular function but do not reproduce brain architecture or the developmental context of L1 syndrome.
iPSC-derived neuronsHuman cellular context
Scientific contextiPSC differentiation into neurons provides a human, variant-defined cellular model for migration, axon guidance, and synaptic phenotypes.
Interpretation boundaryiPSC models reflect cellular phenotypes; extrapolation to brain structure and clinical severity requires additional evidence.
Organoids3D tissue context
Scientific contextBrain organoids can model aspects of ventricular and cortical development relevant to L1CAM function in a three-dimensional context.
Interpretation boundaryOrganoid maturity and reproducibility vary; results complement rather than replace in vivo observations.
Animal modelsDevelopmental and behavioral readouts
Scientific contextMouse models with L1cam disruption reproduce neuroanatomical defects including hydrocephalus and callosal abnormalities, enabling developmental and behavioral phenotyping.
Interpretation boundarySpecies differences in brain development and X-linked genetics require careful matching of model to hypothesis.
Research Workflow
How is an L1CAM gene-function study structured?
A complete validation program moves from construct generation through expression, phenotype, and rescue experiments to data interpretation. Each step produces its own evidence and should not be skipped or conflated.
02
Expression
Verify Expression and Localization
Confirm transcript and protein levels, membrane localization, and post-translational processing to ensure the variant is actually expressed rather than degraded or misfolded.
03
Function
Measure Adhesion and Migration
Quantify adhesion, neurite outgrowth, fasciculation, and migration in the chosen model to detect functional consequences of the variant relative to wild type.
04
Phenotype
Score Disease-Relevant Phenotypes
In organoid or animal models, score neuroanatomical outcomes such as ventricular morphology and callosal integrity, plus behavioral readouts where the model supports them.
05
Rescue
Run Rescue Experiments
Restore wild-type L1CAM expression to test whether the phenotype is rescued, distinguishing variant causality from off-target or background effects.
06
Interpretation
Interpret with Controls
Compare against positive and negative controls, account for experimental replicates, and state the model-specific limits before drawing conclusions about variant-disease relationships.
Related Research Services
How does Creative Biolabs support L1CAM research?
The services below bridge gene editing, model development, vector design, and functional assays. Each entry indicates the typical input and the deliverable; scope, timing, and feasibility are confirmed case by case.
Gene editingVariant introduction
Service scopeIntroduce defined L1CAM variants or knockouts into cell lines and stem cells using gene editing and gene knockout approaches.
Input and deliverableProvide target sequence, desired variant, and cell background; receive validated, sequence-confirmed edited clones with characterization data.
Disease modelingPhenotypic models
Service scopeBuild disease-relevant models through disease modeling gene editing and iPSC differentiation into neural lineages.
Input and deliverableProvide the variant, model preference, and target readout; receive characterized models with QC and baseline phenotypic data.
Vector designExpression systems
Service scopeDesign and produce expression vectors, including AAV vector development and lentiviral vector production, for wild-type or variant L1CAM delivery.
Input and deliverableProvide the coding sequence and expression requirements; receive titered, characterized vector with supporting QC documentation.
Functional assaysPhenotypic readouts
Service scopeMeasure adhesion, neurite outgrowth, migration, and expression to test variant consequences in the chosen cell or organoid model.
Input and deliverableProvide the constructs or edited cells and the target endpoint; receive processed data with methods, controls, replicates, and interpretation notes.
Conflicting Evidence and Limitations
How should L1CAM associations be interpreted?
Gene-disease associations should be read as research findings, not causal certainties. Several factors affect how confidently a variant can be linked to a phenotype.
-
Association is not causation.
Establishing that a L1CAM variant is pathogenic requires functional evidence, segregation data, and rescue experiments. Association alone does not demonstrate mechanism.
-
Spectrum and expressivity.
L1 syndrome spans HSAS, MASA syndrome, and callosal agenesis; the same variant class can produce different severities. Genotype-phenotype correlation remains incomplete.
-
Genetic heterogeneity.
Phenotypes such as corpus callosum agenesis have multiple genetic causes. L1CAM is one contributor and should not be assumed without molecular confirmation.
-
Model limitations.
Cell, iPSC, organoid, and animal models differ in developmental context and species biology. Extrapolation to human disease requires caution.
-
Oncology findings.
L1CAM's reported roles in cancer are context-dependent research observations, not clinical claims, and require independent validation.
-
No diagnostic or treatment advice.
This page is for research use only. It does not provide diagnostic, prognostic, or therapeutic recommendations.
Selected Reading
References for L1CAM and Associated Diseases
Authoritative sources anchor the gene identity, function, and disease associations described on this page. Key facts are cited close to the relevant claim; review dates are noted where information may change.
01
OMIM 308840
L1 Syndrome and L1CAM
OMIM entry for L1 cell adhesion molecule (L1CAM), documenting the X-linked L1 syndrome spectrum including HSAS, MASA syndrome, and corpus callosum agenesis.
View OMIM entry
02
UniProt P32004
L1CAM Protein Structure and Function
UniProt reference for the L1CAM protein, including its immunoglobulin-like and fibronectin type III domains and its role in nervous system development.
View UniProt entry
From Question to Evidence
Creative Biolabs Support
Creative Biolabs can support L1CAM-associated disease research through gene editing, model development, vector production, and functional characterization. The services below map to the validation steps described on this page.
01 / GENE EDITING
Variant introduction and knockout
Introduce defined L1CAM variants or knockouts into cell lines and stem cells, then confirm the edit by sequencing. Edited clones provide a controlled background for functional comparison.
02 / MODELING
Disease modeling and iPSC
Build disease-relevant cellular models using disease-modeling gene editing and iPSC differentiation into neural lineages, with baseline characterization for downstream phenotypic assays.
03 / VECTOR DESIGN
AAV and lentiviral vectors
Design and produce expression vectors for wild-type or variant L1CAM delivery, with titer and characterization data to support transduction studies.
04 / FUNCTIONAL ASSAY
Adhesion and migration readouts
Quantify adhesion, neurite outgrowth, migration, and expression to test variant consequences in the chosen model, with appropriate controls and replicates.
Selected Reading
References
L1CAM · Gene Identity & Function
Moos M, Tacke R, Scherer H, et al. Neural adhesion molecule L1 as a member of the immunoglobulin superfamily with binding domains similar to fibronectin. Nature. 1988;334(6184):701-703. https://doi.org/10.1038/334701a0.
L1CAM · Protein Structure
Schürmann G, Haspel J, Grumet M, Erickson HP. Cell adhesion molecule L1 in folded (horseshoe) and extended conformations. Mol Biol Cell. 2001;12(6):1765-1773. https://doi.org/10.1091/mbc.12.6.1765.
L1CAM · L1 Syndrome
Weller S, Gärtner J. Genetic and clinical aspects of X-linked hydrocephalus (L1 disease): Mutations in the L1CAM gene. Hum Mutat. 2001;18(1):1–12. https://doi.org/10.1002/humu.1144.
L1CAM · Nervous System Development
Maness PF, Schachner M. Neural recognition molecules of the immunoglobulin superfamily: signaling transducers of axon guidance and neuronal migration. Nat Neurosci. 2007;10(1):19–26. https://doi.org/10.1038/nn1827.
L1CAM · Cancer Biology
Altevogt P, Doberstein K, Fogel M. L1CAM in human cancer. Int J Cancer. 2016;138(7):1565–1576. https://doi.org/10.1002/ijc.29658.
Selected sources cover L1CAM gene identity, function, and disease associations. Last verified November 2026. Clinical-stage information changes over time and is not provided on this page.
Scientific Questions
Questions About L1CAM and Associated Diseases
Direct answers about gene function, disease association, validation models, and interpretation of experimental findings.
L1CAM encodes the L1 cell adhesion molecule, a type I membrane glycoprotein of the immunoglobulin superfamily. It supports neuronal migration, axon guidance, adhesion, fasciculation, and synaptic plasticity during nervous system development.
L1 syndrome is an X-linked spectrum caused by pathogenic L1CAM variants, including X-linked hydrocephalus with aqueductal stenosis (HSAS), MASA syndrome, and partial agenesis of the corpus callosum. Severity varies by variant and genetic background.
Options include neuronal cell lines, iPSC-derived neurons, brain organoids, and mouse models. Each answers a different question — from adhesion and migration readouts to neuroanatomical and behavioral phenotypes — and carries its own limitations.
Establishing pathogenicity requires functional evidence, segregation in families, and ideally rescue experiments. Association alone does not prove causation, and gene-disease links should be read as research findings rather than causal certainties.
Creative Biolabs supports gene editing, disease modeling, vector design, and functional assays for L1CAM-associated disease research. Scope, inputs, and deliverables are confirmed case by case with our scientific team.
No. This page is provided for research use only and does not offer diagnostic, prognostic, or therapeutic recommendations. Clinical questions should be directed to qualified healthcare professionals.
Start Your Project Today
Tell us about your project, and our experts will get back to you with a customized quote and proposal.
